Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy

Clinical trial NCT02891850 · COMPLETED

Trial details

NCT number: NCT02891850
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2017-01-11
Primary completion: 2020-01-29
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.